NCT03293927View on ClinicalTrials.gov

Polypharmacy-related Adverse Events in Critically Ill Children

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 9, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Delirium
Interventions
DRUG

Fentanyl

The patient will receive IV fentanyl

DRUG

Dexmedetomidine

The patient will receive IV dexemedetomidine

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT03293927 - Polypharmacy-related Adverse Events in Critically Ill Children | Biotech Hunter | Biotech Hunter